WAVE Life Sciences Ltd banner

WAVE Life Sciences Ltd
NASDAQ:WVE

Watchlist Manager
WAVE Life Sciences Ltd Logo
WAVE Life Sciences Ltd
NASDAQ:WVE
Watchlist
Price: 13.16 USD 0.53% Market Closed
Market Cap: $2.4B

Profitability Summary

WAVE Life Sciences Ltd's profitability score is 29/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score
29/100
Profitability
Score

Margins

Earnings Waterfall
WAVE Life Sciences Ltd

Margins Comparison
WAVE Life Sciences Ltd Competitors

Country Company Market Cap Operating
Margin
Net
Margin
SG
WAVE Life Sciences Ltd
NASDAQ:WVE
2.4B USD
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
959.3B USD
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.3B USD
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
291.8B CHF
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
238.2B GBP
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
242.2B CHF
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
305.1B USD
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.4B USD
Loading...
Loading...
UK
GSK plc
XETRA:GS71
103.6B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
WAVE Life Sciences Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SG
WAVE Life Sciences Ltd
NASDAQ:WVE
2.4B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
959.3B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.3B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
291.8B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
238.2B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
242.2B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
305.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.4B USD
Loading...
Loading...
Loading...
Loading...
UK
GSK plc
XETRA:GS71
103.6B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
WAVE Life Sciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate